Vidyalakshmi Sethunath

Author

Baylor College of Medicine ORCID

Also Known As

V Sethunath, V. Sethunath, Vidyalakshmi Sethunath

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Baylor College of Medicine Harvard University Dana-Farber Cancer Institute Broad Institute University of Houston

About

Vidyalakshmi Sethunath is an author at Baylor College of Medicine specializing in breast cancer, oncology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	36
2	Engineering	1	1	11
3	Cell Biology	1	1	11
4	Pathology	1	1	25
5	Pharmacology	1	1	11

Vidyalakshmi Sethunath

Publications

802

Citations

H-Index

Page 1

	Year	Citations
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer Xiaoyong Fu, Resel Pereira, Carmine De Angelis, Proceedings of the National Academy of Sciences	2019	164
HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer Xiaowei Xu, Carmine De Angelis, Kathleen A. Burke, Clinical Cancer Research	2017	122
Integrative clinical and molecular characterization of translocation renal cell carcinoma Ziad Bakouny, Ananthan Sadagopan, Praful Ravi, Cell Reports	2022	110
Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, Clinical Cancer Research	2021	91
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy Carmine De Angelis, Chandandeep Nagi, Cliff C. Hoyt, Clinical Cancer Research	2019	81
Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer Vidyalakshmi Sethunath, Huizhong Hu, Carmine De Angelis, Molecular Cancer Research	2019	59
Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer Pawan Upadhyay, Sudhir Nair, Ekjot Kaur, Oncotarget	2016	48
Drug-sensitiveFGFR3 mutations in lung adenocarcinoma Pratik Chandrani, Kumar Prabhash, Ratnam Prasad, Annals of Oncology	2016	48
GPCRs profiling and identification of GPR110 as a potential new target in HER2+ breast cancer Raksha R. Bhat, Puja Yadav, Debashish Sahay, Breast Cancer Research and Treatment Tumor BiologyHer2+ Breast CancerBreast OncologyEndocrine-related CancerMedicine	2018	25
Integrative Clinical and Molecular Characterization of Translocation Renal Cell Carcinoma Ziad Bakouny, Ananthan Sadagopan, Praful Ravi,	2021	16

Page 1